STAAR Surgical Company (STAA) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on STAAR Surgical Company (STAA) is Neutral.

The composite score behind that read is -0.08, weighing +0.08 of bullish evidence against -0.21 bearish.

STAAR Surgical Company last closed at $21.67, -3.17% on the session.

Against the IVW growth benchmark the position is -3.97% over the forecast window.

The read is built from 15 underlying insights — 2 bullish and 13 bearish.

Agreement across those insights is 87%.

19 graded predictions for STAA so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks STAAR Surgical Company in the 2nd percentile on valuation and the 41st percentile on return on equity, where 100 is best.

STAAR Surgical Company is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $1.12B.

StockMap tracks STAAR Surgical Company as the 55th largest of the 140 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 122 Neutral, 16 Moderate Underperform and 2 Moderate Outperform.

On that composite STAAR Surgical Company ranks 91st of 140 in the group, against a group median of -0.03.